LONDON (Reuters) – Omicron-adapted vaccines will be delivered to the European Union within days of regulatory approval, a European member of parliament, Peter Liese, said on Wednesday.
The European Medicines Agency (EMA) is expected to make a decision later this week on vaccines made by Moderna and Pfizer-BioNTech tailored to target the older Omicron variant BA.1 as well as the original strain that emerged in China.
(Reporting by Natalie Grover in London; editing by Jason Neely)
